Delivery Order SPE2DB20D3101-SPE2DB23FRSJ5

Award Date 7/21/23
Potential Completion Date 7/24/23
Potential Value $533
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from August 11-14, 2023. The contract was awarded utilizing the Defense Logistics Agency's Pharmaceutical Prime Vendor program, which provides pharmaceuticals and other medical supplies to...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754.26 firm fixed price delivery order by the Defense Logistics Agency to supply 50mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for performance in Conshohocken, Pennsylvania from August 4-7, 2023. As the prime contractor for delivery order under an unspecified agency-wide contract vehicle, Amerisourcebergen will fulfill the Defense Logistics Agency's requirement for this...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $334.47 firm fixed price delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication, for performance at its Conshohocken, Pennsylvania facility from July 21-24, 2023. The award is issued against the DLA's pharmaceutical prime vendor contract vehicle to support the medical readiness of DOD personnel. No subcontractors...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $502.86 delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania. Performance will take place from August 30 to August 31, 2023 under firm fixed pricing. The award was issued against DLA's prime vendor pharmaceutical contracts to support the medical readiness programs...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone treatment, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and provisioning medical...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251,420 delivery order by the Defense Logistics Agency to supply XYOSTED 75 MG/0.5 ML auto-injectors. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing over a period of four days from August 4th through the 7th of 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,508.58 delivery order contract by the Defense Logistics Agency to supply XYOSTED, a testosterone replacement therapy medication. Performance will take place in Conshohocken, Pennsylvania over a one day period from July 26-27, 2023. The firm fixed price contract was awarded under the DLA's pharmaceuticals and medical/surgical supply vehicle. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $6,165.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. The place of performance will be in Conshohocken, Pennsylvania over the period of August 1-2, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling this order to supply the injectable testosterone cypionate product in support of DLA programs. No major...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a testosterone replacement drug. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 30th to August 31st, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,443.02 from the Defense Logistics Agency (DLA) to supply 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 2, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with DLA Troop Support Medical to provide pharmaceuticals and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRSJ5
    Delivery Order

Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $533 delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The firm fixed price contract was issued utilizing the DLA's Pharmaceutical Prime Vendor program, which centrally manages pharmaceuticals for the Department of Defense and other federal agencies. No subcontractors or set-aside designations were associated with this short-term order to support the DLA's provision of pharmaceuticals to military treatment facilities in the region.

Generated 12/20/23, 5:29 AM